Co-Diagnostics
CODX
10 hedge funds and large institutions have $898K invested in Co-Diagnostics in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
15% more capital invested
Capital invested by funds: $778K → $898K (+$120K)
0.02% less ownership
Funds ownership: 0.19% → 0.17% (-0.02%)
9% less funds holding
Funds holding: 11 → 10 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$278K |
| 2 |
Barclays
London,
United Kingdom
|
+$60.3K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$22.6K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$1.83K |
| 5 |
GRP
Global Retirement Partners
San Rafael,
California
|
+$199 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$225K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$90K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7.88K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $609K | +$278K | +8,363 | +74% |
|
2
HighTower Advisors
Chicago,
Illinois
| $134K | – | – | – |
|
|
3
Barclays
London,
United Kingdom
| $75K | +$60.3K | +1,815 | +294% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $49K | – | – | – |
|
|
5
Citadel Advisors
Miami,
Florida
| $21K | +$22.6K | +680 | New |
|
6
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $4K | – | – | – |
|
|
AG
7
Advisor Group
Phoenix,
Arizona
| $3K | – | – | – |
|
|
8
Victory Capital Management
San Antonio,
Texas
| $2K | +$1.83K | +55 | New |
|
|
9
UBS Group
Zurich,
Switzerland
| $1K | -$7.88K | -237 | -91% |
|
|
SM
10
Sabby Management
Miami Beach,
Florida
| – | -$225K | -9,320 | Closed |
|
|
CH
11
CVI Holdings
Wilmington,
Delaware
| – | -$90K | -3,644 | Closed |
|
|
12
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$8K | -333 | Closed |
|
|
13
Bank of America
Charlotte,
North Carolina
| – | -$1K | -43 | Closed |
|
|
GRP
14
Global Retirement Partners
San Rafael,
California
| – | +$199 | +6 | New |
|
CODX Hedge Fund Activity: Q3 2019 in Review
10 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q3 2019, worth a combined $898K — up 15% from $778K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CODX and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.
The largest buyer was Vanguard Group, adding an estimated $278K. The largest seller was Sabby Management, exiting entirely with an estimated $225K sold.
- 10 institutional investors held Co-Diagnostics (CODX) as of Q3 2019, down from 11 in Q2 2019.
- Funds reported $898K of Co-Diagnostics stock for Q3 2019, up 15% quarter-over-quarter.
- 3 funds opened new Co-Diagnostics positions in Q3 2019 and 4 closed out, a net change of -1 holder.
- The largest Co-Diagnostics buyer in Q3 2019 was Vanguard Group, an estimated $278K added.
- The largest Co-Diagnostics seller in Q3 2019 was Sabby Management, an estimated $225K sold.
Based on aggregated 13F filings for Q3 2019.